Skip to main content

Advertisement

SpringerLink
Log in

Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Noris M, Remuzzi G (2005) Hemolytic uremic syndrome. J Am Soc Nephrol 16:1035–1050

    Article  CAS  PubMed  Google Scholar 

  2. Noris M, Remuzzi G (2009) Atypical hemolytic-uremic syndrome. N Engl J Med 361:1675–1687

    Article  Google Scholar 

  3. Nester CM, Thomas CP (2012) Atypical hemolytic uremic syndrome: what is it, how is it diagnosed, and how is it treated. Hematology Am Soc Hematol Educ Program 2012:617–625

    PubMed  Google Scholar 

  4. Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Bettinaglio P et al (2006) Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108:1267–1279

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Kavanagh D, Goodship TH (2011) Atypical hemolytic syndrome, genetic basis, and clinical manifestation. Hematology Am Soc Hematol Educ Program 2011:15–20

    Article  PubMed  Google Scholar 

  6. Loirat C, Garnier A, Sellier-Leclerc AL, Kwon T (2010) Plasma therapy in atypical hemolytic uremic syndrome. Semin Thromb Hemost 36(6):673–681

    Article  PubMed  Google Scholar 

  7. Fakhouri F, Roumenina L, Provot F, Sallée M, Caillard S, Couzi (2010) Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol 21(5):859–867

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Taylor CM, Machin S, Wigmore SJ, Goodship THJ (2010) Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom. Br J Haematol 148(1):37–47

    Article  CAS  PubMed  Google Scholar 

  9. Mache CJ, Acham-Roschitz B, Frémeaux-Bacchi V, Kirschfink M, Zipfel PF, Roedl S et al (2009) Complement inhibitor eculizumab in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 4:1312–1316

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Informed consent was obtained from all patients included in the study.

Author information

Authors and Affiliations

  1. Hematology Department, Hospital Universitari i Politècnic La Fe, Bulevard Sur s/n, Valencia, 46026, Spain

    Carolina Cañigral, Federico Moscardó, Aima Lancharro, Pilar Solves, Javier de la Rubia, Nelly Carpio & Miguel A. Sanz

  2. Nephrology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain

    Cristina Castro

  3. Anesthesiology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain

    Azucena Pajares

Authors
  1. Carolina Cañigral
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Federico Moscardó
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cristina Castro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Azucena Pajares
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Aima Lancharro
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pilar Solves
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Javier de la Rubia
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Nelly Carpio
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Miguel A. Sanz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Federico Moscardó.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cañigral, C., Moscardó, F., Castro, C. et al. Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome. Ann Hematol 93, 1421–1422 (2014). https://doi.org/10.1007/s00277-013-1970-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-013-1970-3

Keywords

Search

Navigation